Literature DB >> 12228246

Agonist recognition sites in the cytosolic tails of vanilloid receptor 1.

Jooyoung Jung1, Soon-Youl Lee, Sun Wook Hwang, Hawon Cho, Jieun Shin, Young-Sun Kang, Sunghoon Kim, Uhtaek Oh.   

Abstract

Vanilloid receptor 1 (VR1), a ligand-gated ion channel activated by vanilloids, acid, and heat, is a molecular detector that integrates multiple modes of pain. Although the function and the biophysical properties of the channel are now known, the regions of VR1 that recognize ligands are largely unknown. By the stepwise deletion of VR1 and by chimera construction using its capsaicin-insensitive homologue, VRL1, we localized key amino acids, Arg-114 and Glu-761, in the N- and C-cytosolic tails, respectively, that determine ligand binding. Point mutations of the two key residues resulted in a loss of sensitivity to capsaicin and a concomitant loss of specific binding to [(3)H]resiniferatoxin, a potent vanilloid. Furthermore, changes in the charges of the two amino acids blocked capsaicin-sensitive currents and ligand binding without affecting current responses to heat. Thus, these two regions in the cytoplasmic tails of VR1 provide structural elements for its hydrophilic interaction with vanilloids and might constitute a long-suspected binding pocket.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228246     DOI: 10.1074/jbc.M207103200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  TRPV1: a stress response protein in the central nervous system.

Authors:  Karen W Ho; Nicholas J Ward; David J Calkins
Journal:  Am J Neurodegener Dis       Date:  2012-04-01

Review 2.  TRP channels entering the structural era.

Authors:  Rachelle Gaudet
Journal:  J Physiol       Date:  2008-06-05       Impact factor: 5.182

3.  A yeast genetic screen reveals a critical role for the pore helix domain in TRP channel gating.

Authors:  Benjamin R Myers; Christopher J Bohlen; David Julius
Journal:  Neuron       Date:  2008-05-08       Impact factor: 17.173

Review 4.  TRPV1: on the road to pain relief.

Authors:  Andrés Jara-Oseguera; Sidney A Simon; Tamara Rosenbaum
Journal:  Curr Mol Pharmacol       Date:  2008-11       Impact factor: 3.339

5.  A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons.

Authors:  Theodore J Price; Amol M Patwardhan; Christopher M Flores; Kenneth M Hargreaves
Journal:  Neuropharmacology       Date:  2005-04-01       Impact factor: 5.250

6.  Desensitization of transient receptor potential ankyrin 1 (TRPA1) by the TRP vanilloid 1-selective cannabinoid arachidonoyl-2 chloroethanolamine.

Authors:  Nikita B Ruparel; Amol M Patwardhan; Armen N Akopian; Kenneth M Hargreaves
Journal:  Mol Pharmacol       Date:  2011-03-25       Impact factor: 4.436

7.  Functional characterisation of the S512Y mutant vanilloid human TRPV1 receptor.

Authors:  Kathy G Sutton; Elizabeth M Garrett; A Richard Rutter; Timothy P Bonnert; Wolfgang Jarolimek; Guy R Seabrook
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

8.  TRPV1 gene deficiency attenuates miniature EPSC potentiation induced by mannitol and angiotensin II in supraoptic magnocellular neurons.

Authors:  Toru Yokoyama; Takeshi Saito; Toyoaki Ohbuchi; Hirofumi Hashimoto; Hitoshi Suzuki; Hiroki Otsubo; Hiroaki Fujihara; Toshihisa Nagatomo; Yoichi Ueta
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

Review 9.  High-resolution views of TRPV1 and their implications for the TRP channel superfamily.

Authors:  Ute A Hellmich; Rachelle Gaudet
Journal:  Handb Exp Pharmacol       Date:  2014

10.  TRPV1: a target for next generation analgesics.

Authors:  Louis S Premkumar; Parul Sikand
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.